Breaking News on Global Pharmaceutical Technology & Manufacturing

Products > Supplier info centre

Request free information:

*
*
*
*
*
*
*
*
*
*
*

Please note that any information that you supply is protected by our Privacy and Cookies Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.

ScinoPharm - Your Complete Source for API Services

ScinoPharm is among the global leaders in the development and manufacture of high-quality active pharmaceutical ingredients (API). The company supports drug development and manufacturing with a full range of API services from process development, production of early phase clinical trial material to large-scale manufacuring for commercial launches.

 

Headquartered in Taiwan, ScinoPharm operates a cGMP facility in full compliance with regulatory standards of US, EU, Japan, Australia, Korea, etc. Out of the 16 manufacturing lines, 6 are capable of handling high potency, cytotoxic compounds including many injectable oncological APIs.

 

At ScinoPharm, R&D has always been seen as essential to future development. The company also focuses on the development of advanced technologies in the fields of peptides and biopharmaceuticals.

 

To address the demands of both multinational companies and local formulation companies, ScinoPharm is constructing a new GMP plant in Changshu, Jiangsu Province, China to provide a wide range of cost-competitive development and manufacturing solutions for key intermediates and APIs.

 

Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector, with over 285 customers around the world including many of the world’s largest brand and generic drug makers.